A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2002
12/04/2002	EP1261644A2 Modulation of the activity of the endothelial cell surface receptor ecrtp/dep-1 in the regulation of angiogenesis
12/04/2002	EP1261639A2 Chondromodulin-i related peptide
12/04/2002	EP1261638A2 Human fgf-23 gene and gene expression products
12/04/2002	EP1261636A2 Human protein kinases and protein kinase-like enzymes
12/04/2002	EP1261635A1 Human polynucleotides, polypeptides, and antibodies
12/04/2002	EP1261623A1 New retinol derivatives, the method of preparations and the uses thereof
12/04/2002	EP1261605A1 Benzoxazole derivatives as tnf and pde iv inhibitors
12/04/2002	EP1261604A1 Compounds having antitumor activity: process for their preparation and pharmaceutical compositions containing them
12/04/2002	EP1261603A1 Flavone derivatives, preparation method and use as medicines
12/04/2002	EP1261601A1 Substituted indoles for modulating nfkb activity
12/04/2002	EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002	EP1261579A1 Dehydroamino acids
12/04/2002	EP1261378A2 Biodegradable immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261364A1 Method of treating or inhibiting cellular injury or cell death
12/04/2002	EP1261361A1 Oral, nasal and pulmonary dosage formualtions of copolymer 1
12/04/2002	EP1261355A1 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response
12/04/2002	EP1261351A2 Nystatin formulation having reduced toxicity
12/04/2002	EP1261349A1 Compounds with chelation affinity and selectivity for first transition series elements and their use
12/04/2002	EP1261337A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/04/2002	EP1261336A2 Il-8 receptor antagonists
12/04/2002	EP1261329A2 Il-8 receptor antagonists
12/04/2002	EP1261328A1 Il-8 receptor antagonists
12/04/2002	EP1261315A2 Echinacea extract as anti-irritant and anti-aging booster in cosmetic compositions
12/04/2002	EP1131304B1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
12/04/2002	EP1109529B1 Use of a lipid extract of the skeletonema algae
12/04/2002	EP1097139B1 Quinoline derivatives
12/04/2002	EP1030867A4 Mammalian milk growth factor
12/04/2002	EP0971961B1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
12/04/2002	EP0907650B1 N- 4-(heteroarylmethyl)phenyl]-heteroarylamines
12/04/2002	EP0814837B1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis
12/04/2002	CN1383379A Method of treatment of seborrheic dermatitis
12/04/2002	CN1382489A Application of alpha-receptor kinetin in preparing medicine
12/04/2002	CN1382482A Medicinal oil for treating leukoderma
12/04/2002	CN1382481A Compound buccal lozenge as Chinese medicine for protecting eyes and refreshing brain
12/04/2002	CN1382480A Non-scar plaster for treating trauma and its preparing process and usage
12/04/2002	CN1382475A Chinese-medicinal aqueogel for treating burn and its preparing process
12/04/2002	CN1382469A Chinese medicine for treating leukoderma
12/04/2002	CN1382458A Bactericidal hemostatic powder
12/04/2002	CN1382449A Compound haparin aqueogel and its preparing process
12/04/2002	CN1382447A Quick-acting ointment for treating dermatitis and eczema
12/04/2002	CN1382438A Repercussive and antipruritic cream and its preparing process
12/04/2002	CN1382437A Application of epigallic catechin 3-gallate in treating HPV infection
12/04/2002	CN1382434A Skin-protecting product
12/04/2002	CN1382433A Use of sunshading agent compsn. contg. malonic dialkyl ester in cosmetics and medicinal preparation
12/04/2002	CN1095377C Medicine for treating skin ringworm and dermatitis and prepn. process
12/04/2002	CN1095375C Medicated cosmetics capable of treating primary and secondary varicose vein simultaneously and its prepn. method
12/04/2002	CN1095368C Tea for beautifying face and reducing fat
12/04/2002	CN1095362C Bath lotion contg. total alkaloid of sophora alopecuroide
12/03/2002	US6489486 2-hydroxyphenyl benzotriazoles as UV-A/B filters
12/03/2002	US6489367 Semifluorinated alkanes and the use thereof
12/03/2002	US6489365 Ltb4-antagonistic compounds for treatment of inflammation, allergy or gastropathy induced by non-steroidal antiinflammatory agents in a warm-blooded animals
12/03/2002	US6489349 Treating an autoimmune disorder with an alkylamine substituted pyridine
12/03/2002	US6489347 Process
12/03/2002	US6489339 C3A receptor ligands
12/03/2002	US6489328 Heterocyclic compounds useful as inhibitors of tyrosine kinases
12/03/2002	US6489327 Tryptase inhibitors
12/03/2002	US6489324 Piperazine compounds as inhibitors of MMP or TNF
12/03/2002	US6489296 Treatment of hypercoagulable states or acquired protein c deficiency with activated protein c, a highly selective therapeutic agent with a low potential for causing bleeding complications
12/03/2002	US6488969 Method for reducing blood ammonia concentration
12/03/2002	US6488960 Corticosteroid formulation
12/03/2002	US6488946 Stable water-in-oil emulsions containing an emulsifier on oleyl-and/or isostearyl-glycoside
12/03/2002	US6488944 1, 1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane
12/03/2002	US6488928 Product for topical application containing a lipase and a hydroxy acid precursor
12/03/2002	US6488922 Applying 1-(n-(2'-nitro-4'-trifluoromethylphenyl)amino)-2,3-propylene to scalp
12/03/2002	US6488915 Use of sunscreen combinations which comprise, as essential constituent, 2-(4-alkoxyanilinomethylene) malonic dialkyl esters as photostable UV filters in cosmetic and pharmaceutical preparations
12/03/2002	US6488646 Swab deliverable actives
12/03/2002	US6488032 Method of providing cosmetic/medical therapy
12/03/2002	CA2283915C The use of alkyl hydrogen fumarates for treating psoriasis, psoriatic arthritis, neurodermatitis and enteritis regionalis crohn
11/2002
11/30/2002	CA2389560A1 Cosmetic and/or dermatological and/or pharmaceutical compound for topical application, containing at least one 3 beta-hydroxysteroid dehydrogenase enzyme inhibitor
11/29/2002	CA2389552A1 Composition for the treatment of cutaneous signs of aging
11/28/2002	WO2002095067A2 INTERFERON α-14 POLYMORPHISM
11/28/2002	WO2002095034A2 A retinoic acid metabolizing cytochrome p450
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002	WO2002095007A2 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	WO2002094872A1 Therapeutic uses of keratinocyte growth factor-2
11/28/2002	WO2002094871A1 Novel keratinocyte growth factor-2 analogue in hair follicle
11/28/2002	WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002	WO2002094824A1 Pyridopyrimidine compounds and their uses
11/28/2002	WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002	WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094814A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
11/28/2002	WO2002094813A1 Novel pyridyl cyanoguanidine compounds
11/28/2002	WO2002094805A1 Chiral compounds
11/28/2002	WO2002094802A1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
11/28/2002	WO2002094754A1 Vitamin d analogues
11/28/2002	WO2002094304A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
11/28/2002	WO2002094296A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/28/2002	WO2002094287A2 Identifying parasitic fungi of the organism, and treatment thereof
11/28/2002	WO2002094263A2 Caspase inhibitors and uses thereof
11/28/2002	WO2002094257A1 Analgesic/antiinflammatory patches for topical use
11/28/2002	WO2002094202A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
11/28/2002	WO2002094193A1 Methods for inhibiting angiogenesis
11/28/2002	WO2002094192A2 Antibodies against tumor necrosis factor delta (april)
11/28/2002	WO2002094189A2 Compositions and methods for treating or preventing convulsions or seizures
11/28/2002	WO2002094019A1 Highly purified antiendotoxin compound
11/28/2002	WO2002080887A3 Timed pulse release composition
11/28/2002	WO2002080858A3 Use of kpv tripeptide for dermatological disorders
11/28/2002	WO2002079408A3 Short bioactive peptides and methods for their use
11/28/2002	WO2002072631A8 Mhc molecule constructs and their usesfor diagnosis and therapy
11/28/2002	WO2002072039A3 Topical preparations and food preparations comprising a pyridoxine-alpha-d-glucose

1 ... 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 ... 1065